Company: TVRD
Filing Date: 2025-10-20
Form Type: S-1/A
Source: 0001104659-25-100896
Chunk: 288

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-10-20
Form: S-1/A
Chunk 288
---
 is 5956 Sherry Lane, Suite 1810, Dallas, TX 75225.

(11)

Consists of shares of common stock issuable upon exercise of stock options held by Mr. Wyzga that are exercisable within 60 days of June 30, 2025.

(12)

Consists of shares of common stock issuable upon exercise of stock options held by Ms. Smith that are exercisable within 60 days of June 30, 2025.

(13)

Consists of (i) 5,612 shares of common stock held by Dr. Shiff and (ii) 8,492 shares of common stock issuable upon exercise of stock options held by Dr. Shiff that are exercisable within 60 days of June 30, 2025.

(14)

Consists of (i) 50,324 shares of common stock beneficially owned by our current directors and executive officers as a group and (ii) 580,075 shares common stock issuable upon the exercise of stock options held by our current directors and executive officers as a group that are exercisable within 60 days of June 30, 2025.

<div align='center'>177</div>

TABLE OF CONTENTS

SELLING STOCKHOLDERS This prospectus relates to the resale by the selling stockholders from time to time of up to an aggregate of 2,084,117 shares of our common stock that were issued to certain investors in the Merger. The selling stockholders may from time to time offer and sell any or all of the shares of our common stock set forth below pursuant to this prospectus and any accompanying prospectus supplement. When we refer to the “selling stockholders” in this prospectus, we mean the persons listed in the table below and their permitted transferees who later come to hold any of the selling stockholders’ interest in the common stock in accordance with the terms of the Registration Rights Agreement, other than through a public sale. The following table sets forth, as of June 30, 2025, the names of the selling stockholders, the aggregate number of shares of common stock beneficially owned by the selling stockholders, the aggregate number of shares of common stock that the selling stockholders may offer pursuant to this prospectus and the number of shares of common stock that would be beneficially owned by the selling stockholders after the sale of the shares of common stock offered hereby assuming that the selling stockholders sell all of the shares of common